Arlington Capital Partners, a Washington, DC-based private equity firm, acquired Molecular Products Group, Ltd., a Harlow, Essex, U.K.-based manufacturer of advanced chemistry-based products serving the healthcare, defense and industrial markets.
The amount of the deal was not disclosed.
The investment will support the company’s expansion of their specialty chemical manufacturing capabilities and the commercialization of its pipeline of air purification products.
Founded in 1924 and led by Troy Rhudy, CEO, Molecular Products primarily specializes in the manufacture and supply of chemical technologies for the treatment of breathable gases serving its global customer base out of its two primary manufacturing facilities in Harlow, Essex, U.K. and Boulder, CO.
The company has over 130 employees with manufacturing operations in Harlow, Essex, U.K. and Boulder CO, and distribution offices in Australia, China and India.